Search Tag: Hologic
Hologic Announces Financial Results for Third Quarter of Fiscal 2017
2017 03 Aug
-- Company Posts Revenue of $806.1 Million, GAAP Diluted EPS of $0.21, and Non-GAAP Diluted EPS of $0.50 ---- Organic Revenue Growth Led by Molecular Diagnostics and International Businesses --Hologic, Inc. (Nasdaq: HOLX) has announced the Company's financial results for the fiscal third quarter ended July 1, 2017. GAAP diluted earnings per share (EPS)... Read more
Hologic to Webcast Presentations at Upcoming Investor Conferences
2017 31 Jul
Hologic, Inc. (Nasdaq: HOLX) has announced that the Company will present at these upcoming investor conferences:The Canaccord Genuity Growth Conference in Boston, MA on Wednesday, August 9 at 4 p.m. Eastern Time (ET).Morgan Stanley's 15th Annual Global Healthcare Conference in New York, NY on Monday, September 11 at 9:55 a.m. ET.Each presenta Read more
Hologic to Announce Financial Results for the Third Quarter of Fiscal 2017 on Wed, August 2, 2017
2017 12 Jul
Hologic, Inc. (Nasdaq: HOLX) has announced that the Company plans to release its financial results for the third quarter of fiscal 2017 on Wednesday, August 2, 2017, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.Interested participants may listen to the call by dialing... Read more
Hologic Notified Holders of 2.00% Convertible Exchange Senior Notes Due 2042 are Eligible to Convert
2017 03 Jul
Hologic, Inc. (Nasdaq: HOLX) has announced that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2042 (CUSIP No. 436440 AC5) issued March 5, 2012, and Wilmington Trust Company, the trustee, paying agent and conversion agent for the notes, that holders are eligible to convert the notes. This conversion right is subject to the... Read more
Hologic's New Panther Fusion® System, Flu and Respiratory Assays Now CE Marked in Europe
2017 29 Jun
New Panther Fusion® Module Expands Molecular Testing Capabilities, Increases Productivity and Flexibility for the LaboratoryHologic, Inc. (Nasdaq: HOLX) has obtained a CE mark in Europe for its new Panther Fusion system and Panther Fusion assays for flu and respiratory testing, the Company has announced. The Fusion module system offers laboratories... Read more
Hologic Announces FDA Clearance of Aptima® Assay to Detect Herpes Simplex Virus 1 & 2
2017 21 Jun
Hologic, Inc. (Nasdaq: HOLX) has announced that it has obtained FDA clearance to market the Aptima® Herpes Simplex Virus (HSV) 1 & 2 molecular assay on the fully automated Panther® system. The test will be commercially available in the 50 United States, U.S. territories and Puerto Rico. According to the U.S. Centers for Disease Control and Prevention,... Read more
Hologic Receives Expanded FDA 510(k) Clearance to Market Cynosure's SculpSure®
2017 16 Jun
SculpSure Now Cleared to Treat Five Areas of the BodyHologic, Inc. (Nasdaq: HOLX) has announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for Cynosure's non-invasive body contouring product, SculpSure, to treat the back and inner and outer thighs. The SculpSure treatment is already FDA-cleared for treatment of... Read more
FDA Approves Hologic's Genius™ 3D Mammography™ Exam
2017 08 Jun
--Genius exam improves cancer detection and reduces recall rates for women of all ages and breast types, including the nearly 50 percent of women of breast cancer screening age who have dense breasts----Separate, recently published data analysis strongly supports starting breast cancer screening using tomosynthesis beginning at age 40--Hologic, Inc.... Read more
Charles J. Dockendorff Elected to Hologic Board of Directors
2017 17 May
Hologic, Inc. (Nasdaq: HOLX) has announced that Charles J. Dockendorff has been elected to the Company's Board of Directors, effective immediately. Mr. Dockendorff also was appointed to the Company's Audit and Finance Committee.Mr. Dockendorff, who has more than 25 years of experience in the global healthcare industry, was formerly the Executive Vice... Read more
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2017 on May 10, 2017
2017 04 Apr
Hologic, Inc. (Nasdaq: HOLX) has announced that the Company plans to release its financial results for the second quarter of fiscal 2017 on Wednesday, May 10, 2017, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.Interested participants may listen to the call by dialing... Read more